Treatment Guidelines: Drug-Resistant TB

Nov 19, 2019 | Kim Rodgers

The U.S. Centers for Disease Control and Prevention (CDC) has released new practice guidelines for the Treatment of Drug-Resistant Tuberculosis, published in the American Journal of Respiratory and Critical Care Medicine. The guidelines were developed by CDC, the American Thoracic Society (ATS), the Infectious Diseases Society of America (IDSA), and the European Respiratory Society.

The new guidelines provide recommendations for treating multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XDR TB), as well as isoniazid-resistant TB. The recommendations prioritize orally-administered medications to make treatment more tolerable and improve patient outcomes; and provide guidance on the choice and number of drugs to use during treatment. Importantly, the recommendations address treatment of contacts to drug-resistant TB cases to prevent future drug-resistant TB disease. Recommendations also cover treatment length, the role of surgery, practices for treating special populations, and monitoring treatment.

The recommendations are evidence-based and were developed with the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) methodology. GRADE involves structured literature review, systematic reviews and meta-analyses of combined data, and expert discussion to assess the certainty in the evidence and determine the strength of each recommendation.

Drug-resistance threatens our ability to treat and control TB. Overall, the percentage of U.S. TB cases that are drug-resistant has been stable; however, treatment of drug-resistant TB is complex and challenging. In 2018, there were 605 cases of isoniazid-resistant TB and 98 cases of MDR TB reported in the United States. When drug-resistant TB is suspected or confirmed, providers should consult a TB expert. State and local TB control programs and the TB Centers of Excellence for Training, Education, and Medical Consultation are excellent resources for drug-resistant TB expertise.

The publication of new drug-resistant TB guidelines is especially timely, as CDC’s Antibiotic Resistance Threats in the United States, 2019 report lists drug-resistant TB as a “serious threat” that requires continued vigilance to maintain the progress we’ve made thanks to effective TB control strategies. Further preventing infections and stopping the spread of TB will save more lives. Through its AR Solutions Initiative, CDC will continue to take a comprehensive approach to antibiotic resistance, including drug-resistant TB, by working with partners to stop the spread of resistance in healthcare, the community, and the environment


About Kim Rodgers

Pronouns: She/Her

Kim Rodgers was formerly the Communications Manager at NACCHO.

More posts by Kim Rodgers

Related Posts

I Stock 1182682774
  • Adverse Childhood Experiences (ACEs)
  • Behavioral Health
  • Community Health
  • Injury and Violence Prevention

Seeking LHD Participants for an Intersectional Data...

With support from the Centers for Disease Control and Prevention, NACCHO is...

Mar 28, 2024 | Camille Adams

Seeking LHD Participants for an Intersectional Data...

World TB Day 2024 1
  • ID Featured
  • Infectious Disease
  • Tuberculosis

Recognizing World TB Day 2024: The Role of Local Health...

LHDs across the nation actively work to eliminate TB through surveillance, case...

Mar 21, 2024 | Kimberly Nalley

Recognizing World TB Day 2024: The Role of Local Health...

I Stock 1318852282
  • COVID-19
  • Immunization
  • Infectious Disease
  • Influenza

Maternal and Child Vaccine Safety - Enhancing Vaccine...

After conducting a Rapid Community Assessment (RCA), in collaboration with the...

Mar 19, 2024 | Victoria Thompson, Clarissa Montes

Maternal and Child Vaccine Safety - Enhancing Vaccine...

Measles Blog 1
  • Tools & Resources
  • Community Health
  • ID Featured
  • Immunization

The Current Status of Measles in the US + Resources to...

This resource round-up aims to help local health departments and healthcare...

Mar 18, 2024 | Irene Halferty, Emma James, Victoria Thompson, Amy Maxson, Robin Mowson

The Current Status of Measles in the US + Resources to...

1

Building Community Resilience Through Maternal and Child...

NACCHO, with funding from the Centers for Disease Control and Prevention’s...

Mar 15, 2024 | Elana Filipos

Building Community Resilience Through Maternal and Child...

  • HIV, STI, & Viral Hepatitis

CDC Study Reveals Increase in Overdoses Associated with...

A recent CDC study demonstrates a need for LHDs and other local harm reduction...

Mar 14, 2024 | Kat Kelley, Anjana Rao, Grace Murtha

CDC Study Reveals Increase in Overdoses Associated with...

1

Bridging Maternal-Child Health (MCH), Infectious Disease...

Funded through the Center for Disease Control and Prevention’s (CDC) National...

Mar 12, 2024 | Elana Filipos

Bridging Maternal-Child Health (MCH), Infectious Disease...

Thumbnail youtube
  • Tools & Resources
  • Adverse Childhood Experiences (ACEs)

NACCHO Releases “Community Partnerships to Prevent...

The National Association of County and City Health Officials is pleased to...

Mar 12, 2024 | Camille Adams

NACCHO Releases “Community Partnerships to Prevent...

1
  • Maternal, Child, & Adolescent Health

NACCHO Provides Funding to Local Health Departments to...

The Maternal, Child, and Adolescent Health team has selected 14 new local...

Mar 11, 2024 | Ryanna Quazi

NACCHO Provides Funding to Local Health Departments to...

Back to Top